Close

Sage Therapeutics (SAGE) PT Lowered to $110 at Guggenheim, Following Pharma Study Fail

December 5, 2019 3:35 PM EST Send to a Friend
Guggenheim analyst Yatin Suneja lowered the price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login